Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'c jun peptide'

Search results for: 'c jun peptide'

Items 61-70 of 93

Page
per page
  1. AMG 487
    B3266 AMG 487
     1 Citation
    Target: CXCR
    Summary: CXCR3 antagonist,potent and selective
  2. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL
  3. PSI-6206
    A8189 PSI-6206
     3 Citation
    Target: HCV polymerase
    Summary: Inhibitor of HCV RNA polymerase,potent and selective
      ≥13.1 mg/mL
  4. Motesanib
    A3632 Motesanib
    Target: VEGFR
    Summary: Inhibitor of Flk-1/Flt-4/PDGFR-/c-Kit
      ≥42 mg/mL
  5. LY2801653
    A3573 LY2801653
    Target: MET
    Summary: MET inhibitor
      ≥27.65 mg/mL
  6. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  7. Zoledronic Acid
    A1352 Zoledronic Acid
    Target: Farnesyl Diphosphate Synthases
    Summary: Potent nitrogen-containing bisphosphonates
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  8. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL
  9. Dovitinib (TKI-258, CHIR-258)
    A2168 Dovitinib (TKI-258, CHIR-258)
     2 Citation
    Target: FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Multitargeted RTK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥36.35 mg/mL
  10. MGCD-265
    A5057 MGCD-265
    Target: VEGFR|c-MET
    Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor
      ≥25.9 mg/mL

Items 61-70 of 93

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 84item
  2. Amino Acids & Building Blocks 2item
  3. Peptides 4item
  4. Peptides & Proteins 1 item
  5. Lab Reagents 2item
Reversibility
  1. Reversible 7item
  2. Irreversible 1 item
Target
  1. Caspases 1 item
  2. Proteasome 4item
  3. Cathepsins 1 item
  4. Bcl-2 1 item
  5. CXCR 1 item
  6. Raf 7item
  7. Aurora Kinases 3item
  8. Gap Junctions 3item
  9. Bromodomains 1 item
  10. AP-1 1 item
  11. MMP 1 item
  12. FLT3 4item
  13. Eph Receptors 1 item
  14. VEGFR 12item
  15. PDGFR 8item
  16. c-Kit 6item
  17. RET 1 item
  18. Thymidylate Synthase 1 item
  19. JNK 2item
  20. Bcr-Abl 1 item
  21. MEK 1 item
  22. FGFR 2item
  23. CGRP receptors 1 item
  24. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  25. MET 5item
  26. Src 3item
  27. Trk Receptors 3item
  28. STAT 1 item
  29. Microtubules/Tubulins 1 item
  30. FAK 1 item
  31. AMPK 1 item
  32. Angiotensin AT2 Receptors 1 item
  33. Toll-like receptors (TLRs) 1 item
  34. c-MET 7item
  35. PKC 3item
  36. Calpains 1 item
  37. HCV Proteases 1 item
  38. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  39. Lyn 1 item
  40. Melanocortin (MC) Receptors 1 item
  41. HIV-1 gp120 1 item
  42. Integrin-ligand interactions 1 item
  43. Tie-2 1 item
  44. C5a receptors 1 item
  45. Farnesyl Diphosphate Synthases 1 item
  46. Ron 1 item
  47. Synthases/Synthetases 1 item
  48. NPY Receptors 1 item
  49. Peptidoglycan synthesis 1 item
  50. DPP-4 1 item
  51. c-Fms tyrosine kinase 1 item
  52. HCV polymerase 2item
  53. PC-PLC 1 item
  54. Lck 1 item
  55. Substance P/NK1 Receptor 1 item
Reported Experiments
  1. Animal Experiments 76item
  2. Cell Experiments 51item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 1 item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 9item
  7. Cancer 45item
  8. Cholangiocarcinoma 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 6item
  11. Colon Carcinoma 2item
  12. Colorectal Cancer 7item
  13. Diabetes 2item
  14. Glioblastoma 3item
  15. Glioma 1 item
  16. HCV 2item
  17. Hepatitis C 1 item
  18. Hepatocellular Carcinoma 1 item
  19. HIV 1 item
  20. Inflammatory Diseases 1 item
  21. Leukemia 2item
  22. Liver Cancer 1 item
  23. Lung Cancer 6item
  24. Lung Carcinoma 2item
  25. Lymphoma 2item
  26. Melanoma 5item
  27. Multiple Myeloma 2item
  28. Non-small Cell Lung Cancer 2item
  29. Ovarian Cancer 3item
  30. Pancreatic Cancer 7item
  31. Prostate Cancer 3item
  32. Renal Cell Carcinoma 4item
  33. Rheumatoid Arthritis 1 item
  34. Thyroid Cancer 4item
  35. Type 2 Diabetes 1 item